Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-04

Clinical Trial Update: A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial update assessing the safety and efficacy of albiglutide in adults with Type 2 diabetes; the study has completed and results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tanzeum (Albiglutide)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2014-06-04